Clinical Research

Thumbnail

RSNA primes 2022 conference attendees for virtual participation, technical exhibits

With its 108th scientific assembly and annual meeting a little more than two weeks away, the Radiological Society of North America is encouraging attendees to experience 2022’s big show virtually—even if they’ll be there in person.

Upped imaging utilization seems to follow ED clinicians who aren’t physicians

Emergency departments that employ nonphysician practitioners probably improve patient access to timely care. However, these EDs also order 5.3% more imaging than their physician-only counterparts.

Medtronic’s Arctic Front cryoballoon catheters

Treating AFib early with cryoablation reduces risk of disease progression, repeat hospitalization

“The evidence shows increasingly that it’s time to rethink how we approach the treatment of AFib,” one researcher said.

3 organizations support 8 ascendant researchers

The American Roentgen Ray Society (ARRS), Strategic Radiology and Bracco Diagnostics have separately elevated early- and mid-career radiologists to heightened educational opportunities.

Lyme disease neuroimaging uncovers compensatory brain repair

Lyme disease patients treated for “brain fog” may develop compensatory alterations in white matter that show up on MRI and correspond—unexpectedly—with slow but sound cognitive performance.

Pandemic anxiety in mothers-to-be shows up in fetal neuroimaging

Pregnant women who felt stressed by healthcare disruptions caused by the COVID-19 pandemic radiated the unease to their developing offspring. The effects were observable on fetal MRI of both brainstem structure and functional activity.

ECMO unit in service at Banner Medical Center in Phoenix.

Early use of ECMO fails to improve cardiogenic shock outcomes, surprising cardiologists

"We expected to see a significant improvement in outcomes for patients with severe or rapidly progressing cardiogenic shock who underwent early ECMO treatment," one specialist said. 

Medtronic’s IN.PACT Admiral DCBs

Drug-coated balloons an effective tool in the battle against femoropopliteal disease

Two late-breaking clinical trials presented at the VIVA Foundation’s VIVA22 conference in Las Vegas highlighted the impact drug-coated balloons can make on patient outcomes.